Deep Reinforcement Learning for Personalized Diagnostic Decision Pathways Using Electronic Health Records: A Comparative Study on Anemia and Systemic Lupus Erythematosus
Lillian Muyama, Antoine Neuraz, Adrien Coulet
TL;DR
This work treats clinical diagnosis as a sequential decision problem and trains DRL agents to generate patient-specific diagnostic pathways from synthetic EHR data for anemia and SLE. By encoding features as acquisition actions and diagnoses as terminal actions, the approach yields explainable step-by-step reasoning and remains robust to noise and missing values, outperforming traditional classifiers under imperfect data in some scenarios. The study shows that dueling DQN with prioritized experience replay achieves strong accuracy while producing concise pathways, and that pathway-based metrics like wPAHM can balance diagnosis quality with pathway efficiency. The results suggest DRL can augment guidelines by learning adaptable, explainable diagnostic processes that generalize to conditions with tree-like or weighted-criteria diagnosis schemas, with future work focusing on real-world EHR validation and multimodal data integration.
Abstract
Background: Clinical diagnosis is typically reached by following a series of steps recommended by guidelines authored by colleges of experts. Accordingly, guidelines play a crucial role in rationalizing clinical decisions but suffer from limitations as they are built to cover the majority of the population and fail at covering patients with uncommon conditions. Moreover, their updates are long and expensive, making them unsuitable for emerging diseases and practices. Methods: Inspired by guidelines, we formulate the task of diagnosis as a sequential decision-making problem and study the use of Deep Reinforcement Learning (DRL) algorithms to learn the optimal sequence of actions to perform in order to obtain a correct diagnosis from Electronic Health Records (EHRs). We apply DRL on synthetic, but realistic EHRs and develop two clinical use cases: Anemia diagnosis, where the decision pathways follow the schema of a decision tree; and Systemic Lupus Erythematosus (SLE) diagnosis, which follows a weighted criteria score. We particularly evaluate the robustness of our approaches to noisy and missing data since these frequently occur in EHRs. Results: In both use cases, and in the presence of imperfect data, our best DRL algorithms exhibit competitive performance when compared to the traditional classifiers, with the added advantage that they enable the progressive generation of a pathway to the suggested diagnosis which can both guide and explain the decision-making process. Conclusion: DRL offers the opportunity to learn personalized decision pathways to diagnosis. We illustrate with our two use cases their advantages: they generate step-by-step pathways that are self-explanatory; and their correctness is competitive when compared to state-of-the-art approaches.
